Gastric transit and pharmacodynamics of a two-millimeter enteric-coated pancreatin microsphere preparation in patients with chronic pancreatitis

Digestive Diseases and Sciences

Volumn 43, Issue 1, 1998, Pages 203-213

  Bruno, Marco J ^a   Borm, Judocus J J ^a   Hoek, Frans J ^a   Delzenne, Barend ^a   Hofmann, Alan F ^a   De Goeij, Jeroen J M ^a   Van Royen, Eric A ^a   Van Leeuwen, Dirk J ^a   Tytgat, Guido N J ^a  

^a NONE

Author keywords

Chronic pancreatitis; Enteric coated microsphere therapy; Enzyme replacement therapy; Erbiumoxide; Exocrine pancreatic insufficiency; Gastric emptying; Pancreatin

Indexed keywords

4 AMINOBENZOIC ACID; BENTIROMIDE; CARBON 14; CARBON DIOXIDE; CHYMOTRYPSIN; ERBIUM; MICROSPHERE; OCTANOIC ACID; PANCREAS ENZYME; PANCREATIN; TECHNETIUM 99M; TRIACYLGLYCEROL LIPASE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BREATH ANALYSIS; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENTERIC COATED TABLET; ENZYME REPLACEMENT; FEMALE; GASTROINTESTINAL TRANSIT; HUMAN; MALE; MEAL; ORAL DRUG ADMINISTRATION; PANCREAS INSUFFICIENCY; PHARMACODYNAMICS; PRIORITY JOURNAL; SCINTIGRAPHY;

4-AMINOBENZOIC ACID; ADULT; AGED; BREATH TESTS; CHOLESTEROL ESTERS; CHRONIC DISEASE; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL TRANSIT; HUMANS; MALE; MICROSPHERES; MIDDLE AGED; PANCREATIN; PANCREATITIS; STOMACH; TABLETS, ENTERIC-COATED; TECHNETIUM;

EID: 0031914790     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018813229334     Document Type: Article

References (48)

1. Graham DY: An enteric-coated pancreatic enzyme preparation that works. Dig Dis Sci 24:906-909, 1979
2. Schneider MU, Knoll-Ruzicka ML, Domschke S, Heptner G, Domschke W: Pancreatic enzyme replacement therapy: Comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhea in chronic pancreatitis. Hepato-Gastroenterol 32:97-102, 1985
3. Dutta SK, Rubin J, Harvey J: Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Gastroenterology 84:476-482, 1983
4. Dutta SK, Tilley DK: The pH-sensitive enteric coated pancreatic enzyme preparations: An evaluation of therapeutic efficacy in adult patients with pancreatic insufficiency. J Clin Gastroenterol 5:51-54, 1983
5. Jorgensen BB, Pedersen NT, Worning H: Monitoring the effect of substitution therapy in patients with exocrine pancreatic insufficiency. Scand J Gastroenterol 26:321-326, 1991
6. Lankisch PG, Lembcke B, Goke B, Creutzfeldt W: Therapy of pancreatogenic steatorrhoea: Does acid protection of pancreatic enzymes offer any advantage? Z Gastroenterol 24:753-757, 1986
7. Littlewood JM, Kelleher J, Walters MP, Johnson AW: In vivo and in vitro studies of microsphere pancreatic supplements. J Pediatr Gastroenterol Nutr 7:S22-S29, 1988
8. Dudder M, Spener F: Comparison of lipase activity in pancreatin formulations. Pharm Z 133:56-66, 1988
9. Otte M, Ridder P, Dageforde J: In-vitro tests of pancreatic enzyme preparations. Dtsch Med Wochenschr 112:1498-1502, 1987
10. Whitehead AM: Study to compare the enzyme activity, acid resistance and dissolution characteristics of currently available pancreatic enzyme preparations. Pharm Weekbl 19(10):12-16, 1988
11. Gan KH, Geus WP, Heijerman HGM, Bakker W, Lamers CBHW: In vitro dissolution profiles of enteric coated microsphere pancreatin preparations at different pH values. Gastroenterology 108:A356, 1995
12. Meyer JH, Elashoff J, Porter Fink V, Dressman J, Amidon GL: Human postprandial gastric emptying of 1-3-millimeter spheres. Gastroenterology 94:1315-1325, 1988
13. Mundlos S, Kuhnelt P, Adler G: Monitoring enzyme replacement treatment in exocrine pancreatic insufficiency using the cholesteryl octanoate breath test. Gut 31:1324-1328, 1990
14. Kuhnelt P, Mundlos S, Adler G: Effect of pellet size of a pancreas enzyme preparation on duodenal lipolytic activity. Z Gastroenterol 29:417-421, 1991
15. Gottschalk B, Wiesemann HG, Stephan U: Comparison of two pancreatic enzyme products for the treatment of maldigestion in cystic fibrosis (mucoviscidosis). Monatschr Kinderhkd 136:626-629, 1988
16. Stern C, Plettner C, Gruttner R: Pancreatic enzyme replacement therapy in cystic fibrosis (CF). Klin Padiatr 200:36-39, 1988
17. Lankisch PG, Lembcke B, Kirchhoff S, Hilgers R, Creutzfeldt W: Treatment of pancreatogenic steatorrhea: A comparison of two acid-protected enzyme preparations. Dtsch Med Wochenschr 113:15-17, 1988
18. Beverley DW, Kelleher J, MacDonald A, Littlewood JM, Robinson T, Walters MP: Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child 62:564-568, 1987
19. Braggion C, Borgo G, Faggionata P, Mastella G: Influence of antacid and formulation on effectiveness of pancreatic enzyme supplementation of cystic fibrosis. Arch Dis Child 62:349-356, 1987
20. Williams J, MacDonald A, Weller PH, Fields J, Pandov H: Two enteric coated microspheres in cystic fibrosis. Arch Dis Child 65:594-597, 1990
21. Thomson M, Claque A, Cleghorn GJ, Shepard RW. Comparative in vitro and in vivo studies of enteric-coated pancrelipase preparations for pancreatic insufficiency. J Pediatr Gastroenterol Nutr 17:407-413, 1993
22. Borm JJJ, Bruno MJ, de Goeij JJM, Moest TF, van Royen EA: Dosimetric optimization of postproduction neutron-activated Erbium-170-oxide-enriched pancreatin. J Nucl Med 36:888-892, 1995
23. Cole SG, Rossi S, Stern A, Hofmann AF: Cholesteryl octanoate breath test. Preliminary studies on a new noninvasive test of human pancreatic exocrine function. Gastroenterology 93:1372-1380, 1987
24. 14C]octanoate breath test and measurement of plasma p-aminobenzoic acid. Clin Chem 41:599-604, 1995
25. Gyr K, Stalder GA, Schiffmann I, Fehr C, Vonderschmitt D, Fahrlaender H: Oral administration of a chymotrypsin-labile peptide - a new test of exocrine pancreatic function in man (PFT). Gut 17:27-32, 1976
26. Borm JJJ, Reinalda WJ, Visser EJ, Wieringa FP, Rijnders AJM, van Royen EA: The use of time-location instead of time-activity curves. Eur J Nucl Med 19:633, 1992
27. Borm JJJ, Tiel-van Buul MMC, Royen van EA: Compressed images and time-location curves for the analysis of two phase gastric emptying studies; First clinical results. Eur J Nucl Med 19:644, 1992
28. van den Bergh FAJTM, Klein Elhorst JT, Hoek FJ, Tytgat GNJ: Rapid determination of the p-aminobenzoic acid excretion index in urine without the use of radioactivity. Clin Chem 32:234-235, 1986
29. Meyer JH, Dressman J, Fink A, Amidon G: Effect of size and density on canine gastric emptying of nondigestible solids. Gastroenterology 89:805-813, 1985
30. Criscuoli G, Moretti S, Cavassini GB: Gastrointestinal transit of non-disintegrating pellets and minitablets, by using three different multiple-unit preparations. Biol Med 16:15-28, 1994
31. Jian R, Assael T, Grall Y, Romary D, Jobin G, Valleur P, Dhamlincourt A-M, Bernier J-J: A comparative study of gastric emptying of digestible solids and inert particles, in healthy and duodenal ulcer patients. Gastroenterol Clin Biol 7:272-276, 1983
32. Holt S, Reid J, Taylor TV, Tothill P, Heading RC: Gastric emptying of solids in man. Gut 23:292-296, 1982
33. Bertrand J, Metman EH, Danquechin-Dorval E, Rouleau P, d'Hueppe A, Itti R, Philippe L: Gastric evacuation time following a standard meal as determined by radio-opaque granules. Clinical applications and validation. Gastroenterol Clin Biol 4:770-776, 1980
34. Güller R, Nemec HW, Kyle L, Fridrich R: Zur messung der magenentleerung solider nahrung. Vergleich zweier solider phasen durch doppel-isotopentechnik. Schweiz Med Wochenschr 107:442-446, 1977
35. Long WB, Weiss JB: Rapid gastric emptying of fatty meals in pancreatic insufficiency. Gastroenterology 67:920-925, 1974
36. Layer P, van de Ohe M, Gröger G, Grandt D, Rünzi M, Goebell H: Late postprandial motility changes in chronic pancreatitis: Pathogenetic role of malabsorption. Gastroenterology 108:A368, 1995
37. Kao D, Hlinka M, Lake R, Graham LS, Meyer JH: Oil empties from the stomach rapidly in human pancreatic insufficiency. Gastroenterology 108:A364, 1995
38. Kravetz RE, Spiro HM: Gastric secretion in chronic pancreatitis. Ann Intern Med 63:776-782, 1965
39. Bank S, Marks IN, Groll A: Gastric acid secretion in pancreatic disease. Gastroenterology 51:649-655, 1966
40. Gupta S, Rao TR: Gastric acid secretion in pancreatic disease. Digestion 12:189-191, 1975
41. Dutta SK, Russell RM, Iber FL: Influence of exocrine pancreatic insufficiency on the intraluminal pH of the proximal small intestine. Dig Dis Sci 24:529-534, 1979
42. Regan PT, Malagelada JR, DiMagno EP, Go VL: Postprandial gastric function in pancreatic insufficiency. Gut 20:249-254, 1979
43. Saunders JH, Cargill JM, Wormsley KG: Gastric secretion of acid in patients with pancreatic disease. Digestion 17:365-369, 1978
44. Gullo L, Corinaldesi R, Casadio R, Vezzadini P, Tomassetti P, Ventrucci M, Priori P, Labo G: Gastric acid secretion in chronic pancreatitis. Hepato-Gastroenterol 30:60-62, 1983
45. Guarner L, Rodriguez R, Guarner F, Malagelada JR: Fate of oral enzymes in pancreatic insufficiency. Gut 34:708-712, 1993
46. Dutta SK, Anand K, Gadacz TR: Bile salt malabsorption in pancreatic insufficiency secondary to alcoholic pancreatitis. Gastroenterology 91:1243-1249, 1986
47. Gielkes HAJ, Eddes EH, Vecht J, Lamers CBHW, Masclee AAM: Postprandial gallbladder motility in pancreatic insufficiency. Gastroenterology 108:A357, 1995
48. Council of Europe (partial agreement) in accordance with the convention of the elaboration of a European pharmacopoeia. European pharmacopoeia, 2nd ed. Sainte-Ruffine, Maisonneuve SA, 1980